<unk><unk>  helps in the confirmation of the diagnosis of<unk><unk><unk><unk> . It allows the identification of mutations in up to 65% of patients with a clinical diagnosis of CPVT. There are HRS/EHRA Expert Consensus Recommendations for<unk><unk>  in<unk><unk><unk><unk> .
Catecholaminergic polymorphic ventricular tachycardia genetic testing
Short QT syndrome genetic testing
Tricuspid regurgitation cardiac stress test
Short QT syndrome electrophysiologic studies
Left ventricular aneurysm CT
Torsades de pointes echocardiography
Noncompaction cardiomyopathy genetic testing
Right bundle branch block echocardiography